Literature DB >> 22293327

Role of thioredoxin in lung disease.

Jian Xu1, Taoping Li, Haiqing Wu, Ting Xu.   

Abstract

Thioredoxin system is a ubiquitous thiol oxidoreductase system that regulates cellular reduction/oxidation (redox) status. It includes thioredoxin (Trx), thioredoxin reductase (TrxR), and NADPH. Trx plays an essential role in cell function by limiting oxidative stress directly via antioxidant effects and indirectly by proteins interaction with key signal transduction molecules. A variety of signaling molecules have been implicated in the cytoprotection conferred by Trx, such as autophagic proteins, p38 mitogen-activated protein kinase, nuclear factor-κB, phosphatidylinositol 3-kinase. Recent studies indicated that Trx may contribute to the pathogenesis of COPD, asthma and lung injury. Enhanced Trx expression or application of recombinant Trx afforded protection in preclinical models of pulmonary tissue injury, which suggested Trx may be used in future therapeutic applications. The focus of this review is on the significance of Trx in various pulmonary diseases, which as a potential therapeutic strategy to protect against oxidative stress and inflammation. Crown Copyright Â
© 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293327     DOI: 10.1016/j.pupt.2012.01.002

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  13 in total

1.  Antioxidants and Chronic Obstructive Pulmonary Disease.

Authors:  Félix-Antoine Vézina; André M Cantin
Journal:  Chronic Obstr Pulm Dis       Date:  2018-10-08

Review 2.  Oxidative Stress in Chronic Obstructive Pulmonary Disease.

Authors:  Peter J Barnes
Journal:  Antioxidants (Basel)       Date:  2022-05-13

3.  Antioxidant Effect of Thioredoxin and Vitamin D3 in Peritoneal Dialysis Patients.

Authors:  Sara Yavuz Ileri; Adnan Batman; Ceyla Eraldemir; Serkan Bakırdogen; Erkan Dervisoglu
Journal:  Biomed Res Int       Date:  2022-05-02       Impact factor: 3.246

4.  Oxidative/Nitrosative stress and the pathobiology of chronic obstructive pulmonary disease.

Authors:  Rajesh Pandey; Mamta Singh; Udita Singhal; Krishna Bihari Gupta; Surendra Kumar Aggarwal
Journal:  J Clin Diagn Res       Date:  2013-03-01

5.  Oxidative Stress and Therapeutic Development in Lung Diseases.

Authors:  Leah Villegas; Timothy Stidham; Eva Nozik-Grayck
Journal:  J Pulm Respir Med       Date:  2014-07-15

6.  Decreased serum level of thioredoxin 1 in female patients with pneumonia and its combinational use with haptoglobin for the specific diagnoses of pneumonia and lung cancer.

Authors:  Mee-Kyung Cha; Il-Han Kim
Journal:  Pneumonia (Nathan)       Date:  2015-12-01

7.  Glutaredoxin 2 Reduces Asthma-Like Acute Airway Inflammation in Mice.

Authors:  Eva-Maria Hanschmann; Carsten Berndt; Christina Hecker; Holger Garn; W Bertrams; Christopher H Lillig; Christoph Hudemann
Journal:  Front Immunol       Date:  2020-11-03       Impact factor: 7.561

Review 8.  Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology.

Authors:  Javier Checa; Josep M Aran
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

9.  Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells.

Authors:  Woo Hyun Park
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

10.  Thioredoxin plays a key role in retinal neuropathy prior to endothelial damage in diabetic mice.

Authors:  Xiang Ren; Chen Li; Junli Liu; Chenghong Zhang; Yuzhen Fu; Nina Wang; Haiying Ma; Heyuan Lu; Hui Kong; Li Kong
Journal:  Oncotarget       Date:  2017-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.